Skip to main content

Table 2 Gout disease characteristics

From: Characteristics of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: a cross-sectional observational study

Variable Gout
Classification criteria Aspirate proven 6 (25 %)
Clinical criteria 18 (75 %)
Disease duration, years, mean (SD) 17 (11)
Age of onset, years, mean (SD) 41 (18)
Acute flares in preceding 3 months, mean (SD) 1.3 (1.4)
1MTPJ flares in preceding 3 months, n (%) 6 (25 %)
History of 1MTPJ flares, n (%) 21 (88 %)
Presence of subcutaneous tophi, n (%) 17 (71 %)
Presence of 1MTPJ tophi, n (%) 6 (25 %)
Number of tophi in feet, mean (SD) 1.9 (3.5)
Total number of tophi, mean (SD) 6.1 (8.7)
Colchicine use, n (%) 13 (54 %)
Urate lowering therapya, n (%) 23 (96 %)
 Allopurinol use, n (%) 19 (79 %)
 Probenecid use, n (%) 3 (12 %)
 Benzbromarone use, n (%) 2 (8 %)
 Febuxostat use, n (%) 2 (8 %)
  1. a3 patients were taking >1 urate lowering agent